Haruhito Sugiyama

3.9k total citations
136 papers, 1.5k citations indexed

About

Haruhito Sugiyama is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Haruhito Sugiyama has authored 136 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 33 papers in Physiology and 30 papers in Infectious Diseases. Recurrent topics in Haruhito Sugiyama's work include Asthma and respiratory diseases (28 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and COVID-19 Clinical Research Studies (19 papers). Haruhito Sugiyama is often cited by papers focused on Asthma and respiratory diseases (28 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and COVID-19 Clinical Research Studies (19 papers). Haruhito Sugiyama collaborates with scholars based in Japan and United States. Haruhito Sugiyama's co-authors include Motoyasu Iikura, Norihiro Kokudo, Masayuki Hojo, Koichiro Kudo, Shinyu Izumi, Nobuyuki Kobayashi, Yuichiro Takeda, Russell J. Hopp, Robert G. Townley and Againdra K. Bewtra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Haruhito Sugiyama

130 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruhito Sugiyama Japan 21 403 352 339 292 238 136 1.5k
Alex Richter United Kingdom 25 518 1.3× 284 0.8× 158 0.5× 650 2.2× 256 1.1× 103 2.2k
Tomoyuki Kakugawa Japan 23 1.1k 2.8× 285 0.8× 321 0.9× 91 0.3× 484 2.0× 95 1.9k
Alessandra Vultaggio Italy 32 464 1.2× 225 0.6× 810 2.4× 154 0.5× 216 0.9× 124 2.9k
Arnaud Petit France 25 156 0.4× 508 1.4× 177 0.5× 141 0.5× 206 0.9× 129 2.3k
Neil A. Accortt United States 23 97 0.2× 270 0.8× 147 0.4× 218 0.7× 543 2.3× 55 1.9k
Gérard Michel France 26 117 0.3× 234 0.7× 193 0.6× 117 0.4× 187 0.8× 77 1.8k
Shao‐Lee Lin United States 17 639 1.6× 169 0.5× 1.1k 3.2× 132 0.5× 342 1.4× 21 2.4k
Edwin Massey United Kingdom 26 89 0.2× 145 0.4× 441 1.3× 420 1.4× 176 0.7× 46 2.3k
Carol Inward United Kingdom 23 176 0.4× 586 1.7× 108 0.3× 144 0.5× 100 0.4× 57 2.2k
Francesco Cinetto Italy 19 362 0.9× 91 0.3× 228 0.7× 181 0.6× 170 0.7× 73 1.1k

Countries citing papers authored by Haruhito Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Haruhito Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhito Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhito Sugiyama more than expected).

Fields of papers citing papers by Haruhito Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhito Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhito Sugiyama. The network helps show where Haruhito Sugiyama may publish in the future.

Co-authorship network of co-authors of Haruhito Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhito Sugiyama. A scholar is included among the top collaborators of Haruhito Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhito Sugiyama. Haruhito Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishii, Satoru, et al.. (2023). Diagnosis of diffuse panbronchiolitis by transbronchial lung cryobiopsy. Heliyon. 9(4). e15127–e15127. 1 indexed citations
2.
Suzuki, Manabu, Akihiro Matsunaga, Tohru Miyoshi‐Akiyama, et al.. (2023). Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial. Drug Discoveries & Therapeutics. 17(5). 304–311. 1 indexed citations
3.
Suzuki, Manabu, Keita Sakamoto, Kentaro Tamura, et al.. (2023). Clinical usefulness of end‐tidal CO2 measured using a portable capnometer in patients with respiratory disease. The Clinical Respiratory Journal. 17(2). 96–104. 2 indexed citations
4.
Yamamoto, Shohei, Kouki Matsuda, Kenji Maeda, et al.. (2023). Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2. BMC Infectious Diseases. 23(1). 282–282. 5 indexed citations
5.
Hashimoto, Masao, Go Naka, Motoyasu Iikura, et al.. (2022). A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma. Thoracic Cancer. 13(14). 2075–2077. 2 indexed citations
6.
Suzuki, Manabu, Masao Hashimoto, Satoru Ishii, et al.. (2022). Endobronchial hamartoma resected via bronchoscopy using high-frequency electrosurgical snare–Preoperative strategies using virtual bronchoscopy. SHILAP Revista de lepidopterología. 17(11). 4232–4238.
7.
Yamamoto, Shohei, Kenji Maeda, Kouki Matsuda, et al.. (2021). Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study. Clinical Infectious Diseases. 75(1). e683–e691. 33 indexed citations
8.
Suzuki, Manabu, Masayuki Hojo, Junko Terada-Hirashima, et al.. (2021). Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan. Respiratory Investigation. 59(4). 569–572. 6 indexed citations
9.
Maeda, Kenji, Nobuyo Higashi‐Kuwata, Noriko Kinoshita, et al.. (2021). Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Scientific Reports. 11(1). 5563–5563. 27 indexed citations
10.
11.
Takeda, Yuichiro, et al.. (2019). Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients. Scientific Reports. 9(1). 19872–19872. 10 indexed citations
12.
Yamamoto, Shota, Motoyasu Iikura, Naoko Nagano, et al.. (2019). Can the Number of Radiofrequency Activations Predict Serious Adverse Events after Bronchial Thermoplasty? A Retrospective Case-Control Study. Pulmonary Therapy. 5(2). 221–233. 3 indexed citations
13.
Izumi, Shinyu, et al.. (2018). A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib. Respiratory Medicine Case Reports. 26. 50–52. 9 indexed citations
14.
Hojo, Masayuki, Tomonori Mizutani, Motoyasu Iikura, et al.. (2013). Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose. Allergology International. 62(1). 91–98. 7 indexed citations
15.
Takeda, Yuichiro, et al.. (2010). A Germ Cell Tumor with a Cavity Containing an Air-fluid Level. Haigan. 50(1). 41–46. 1 indexed citations
16.
Hirano, Satoshi, Kazumi Sano, Yuichiro Takeda, et al.. (2009). [A case of lung adenocarcinoma successfully treated with dose-reescalated gefitinib after resistance was acquired].. PubMed. 36(8). 1333–6. 2 indexed citations
17.
Sugiyama, Haruhito, et al.. (1995). [Pulmonary involvement in immunoblastic lymphadenopathy: case reports and review of literature published in Japan].. PubMed. 33(11). 1276–82. 4 indexed citations
18.
Sugiyama, Haruhito, et al.. (1995). Eosinophil Accumulation and Activation in Antigen-Induced Late Asthmatic Response in Guinea Pigs. Journal of Asthma. 32(1). 37–45. 7 indexed citations
19.
Okada, Chiharu, Ryosuke Eda, Haruhito Sugiyama, et al.. (1994). Effect of Cetirizine on Human Eosinophil Superoxide Generation, Eosinophil Chemotaxis and Eosinophil Peroxidase in vitro. International Archives of Allergy and Immunology. 103(4). 384–390. 28 indexed citations
20.
Kobayashi, Nobuyuki, Hajime Takizawa, Haruhito Sugiyama, et al.. (1989). [A case of dermatomyositis which rapidly developed to respiratory failure in the presence of pneumomediastinum].. PubMed. 27(7). 848–54. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Richter Breakdown of academic impact, for papers by Tomoyuki Kakugawa Breakdown of academic impact, for papers by Alessandra Vultaggio Breakdown of academic impact, for papers by Arnaud Petit Breakdown of academic impact, for papers by Neil A. Accortt Breakdown of academic impact, for papers by Gérard Michel Breakdown of academic impact, for papers by Shao‐Lee Lin Breakdown of academic impact, for papers by Edwin Massey Breakdown of academic impact, for papers by Carol Inward Breakdown of academic impact, for papers by Francesco Cinetto
Rankless by CCL
2026